Characterization of a novel MR‐detectable nanoantioxidant that mitigates the recall immune response
Open Access
- 24 August 2016
- journal article
- research article
- Published by Wiley in NMR in Biomedicine
- Vol. 29 (10) , 1436-1444
Abstract
In many human diseases, the presence of inflammation is associated with an increase in the level of reactive oxygen species (ROS). The resulting state of oxidative stress is highly detrimental and can initiate a cascade of events that ultimately lead to cell death. Thus, many therapeutic attempts have been focused on either modulating the immune system to lower inflammation or reducing the damaging caused by ROS. Berlin et al. reported the development of a novel nanoantioxidant known as poly(ethylene glycol)‐functionalized‐hydrophilic carbon clusters (PEG‐HCCs). They showed that PEG‐HCCs could be targeted to cancer cells, utilized as a drug delivery vector, and can even be visualized ex vivo. Our work here furthers this work and characterizes Gd‐DTPA conjugated PEG‐HCCs and explores the potential for in vivo tracking of T cells in live mice. We utilized a mouse model of delayed‐type hypersensitivity (DTH) to assess the immunomodulatory effects of PEG‐HCCs. The T1‐agent Gd‐DTPA was then conjugated to the PEG‐HCCs and T1 measurements, and T1‐weighted MRI of the modified PEG‐HCCs was done to assess their relaxivity. We then assessed if PEG‐HCCs could be visualized both ex vivo and in vivo within the mouse lymph node and spleen. Mice treated with PEG‐HCCs showed significant improvements in the DTH assay as compared to the vehicle (saline)‐treated control. Flow cytometry demonstrated that splenic T cells are capable of internalizing PEG‐HCCs whereas fluorescent immunohistochemistry showed that PEG‐HCCs are detectable within the cortex of lymph nodes. Finally, our nanoantioxidants can be visualized in vivo within the lymph nodes and spleen of a mouse after addition of the Gd‐DTPA. PEG‐HCCs are internalized by T cells in the spleen and can reduce inflammation by suppression of a recall immune response. PEG‐HCCs can be modified to allow for both in vitro and in vivo visualization using MRI. © 2016 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd.Keywords
Funding Information
- NIH (NCI P30-CA125123)
- Department of Defense (W81XWH-08-2-0143)
This publication has 16 references indexed in Scilit:
- Mitochondria, oxidative stress and neurodegenerationJournal of the Neurological Sciences, 2012
- Tracking T-cells in vivo with a new nano-sized MRI contrast agentNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Antioxidant Carbon Particles Improve Cerebrovascular Dysfunction Following Traumatic Brain InjuryACS Nano, 2012
- Effective Drug Delivery, In Vitro and In Vivo, by Carbon-Based Nanovectors Noncovalently Loaded with Unmodified PaclitaxelACS Nano, 2010
- 19F MRI for quantitative in vivo cell trackingTrends in Biotechnology, 2010
- Fluorine‐19 MRI for visualization and quantification of cell migration in a diabetes modelMagnetic Resonance in Medicine, 2007
- Oxidative Stress, Mitochondrial Dysfunction, and Stress Signaling in Alzheimers DiseaseCurrent Alzheimer Research, 2006
- Mitochondrial Dysfunction and Reactive Oxygen Species in Excitotoxicity and Apoptosis: Implications for the Pathogenesis of Neurodegenerative DiseasesNeurochemical Research, 2003
- Mitochondrial damage induced by conditions of oxidative stressFree Radical Biology and Medicine, 1999
- Alzheimer's disease and oxidative stress: implications for novel therapeutic approachesProgress in Neurobiology, 1999